Using Patient-Reported Outcomes to Show Pharmacy’s Value
Pharmacy services influence far more than dispensing accuracy. A pharmacist may help a person breathe more easily, take medicines consistently, manage side effects, understand a new diagnosis, or feel confident seeking support for a sensitive health concern. Yet these benefits can be difficult to demonstrate through dispensing volumes, prescription counts, or clinical measures alone.
Patient-reported outcomes (PROs) provide a structured way to capture what changes from the patient’s perspective. They can measure symptoms, daily functioning, treatment confidence, medication-related problems, health behaviours, and quality of life before and after a pharmacy intervention. Patient-reported experience measures (PREMs) add information about access, communication, trust, and the overall service encounter.
For Australian pharmacies, this evidence is increasingly relevant as services expand beyond supply. Community pharmacists contribute to vaccination, medication reviews, chronic disease support, opioid dependence treatment, smoking cessation, wound care, and health promotion. A pharmacy in suburban Melbourne may serve a different population from one in regional Queensland, yet both need credible ways to show whether their work produces meaningful benefits.
A well-designed outcomes process should be clinically useful without creating an unreasonable administrative burden. The aim is to listen consistently, respond to what patients report, and use the findings to improve care. When patient feedback is connected to professional judgement and service data, pharmacies can present a clearer account of their contribution to individual and community health.
| Measurement approach | What it captures | Useful pharmacy application | Main limitation |
|---|---|---|---|
| Patient-reported outcomes | Symptoms, function, confidence and quality of life | Chronic disease reviews and medication support | Can be affected by recall and health literacy |
| Patient-reported experience measures | Communication, access and satisfaction | Service design and staff training | Positive experiences do not always mean clinical improvement |
| Clinical indicators | Blood pressure, glucose, weight or adherence data | Monitoring treatment and risk | May miss burden, priorities and daily functioning |
| Operational measures | Waiting time, service uptake and follow-up rates | Workflow and business management | Shows activity more clearly than impact |
Choosing Outcomes That Matter
The best measure begins with the service goal. If a pharmacy runs an asthma support program, relevant outcomes might include fewer night-time symptoms, greater confidence using a preventer, fewer reliever-only days, and less disruption to work or school. If the service focuses on medication adherence, the patient may report fewer missed doses, a simpler routine, or reduced concern about adverse effects.
A short baseline assessment followed by a planned review can reveal change more clearly than a single satisfaction survey. Pharmacists should agree on when the outcome will be measured, who will collect it, and how the result will influence care. A two-week follow-up may suit an inhaler technique intervention, while a three-month interval may be more appropriate for cardiovascular risk management.
Patient priorities should shape the questions. A person living with chronic pain may value being able to walk to the shops, while a patient with depression may prioritise sleep, concentration, or the ability to maintain social contact. Generic quality-of-life tools can support comparison, but a small number of service-specific questions often make the results more meaningful in everyday practice.
Building PRO Collection into Workflow
Patient-reported data should fit naturally into the pharmacy journey. Collection may occur through a tablet at the consultation desk, a secure digital form sent before an appointment, or a brief conversation recorded in the dispensing or clinical documentation system. The method needs to suit the patient, the service and the pharmacy’s privacy arrangements.
A busy community pharmacy cannot ask every person to complete a lengthy questionnaire. Short validated instruments, plain language and optional assistance can improve completion. Pharmacists should explain why the questions matter and make clear that a patient can decline without affecting access to medicines or care.
The process must also include a response pathway. A concerning symptom score, a report of suicidal thoughts, or a statement that a person cannot manage their medicines should trigger appropriate assessment, referral or escalation. PRO collection is ethically weak if information is gathered, stored and then ignored.
Digital tools can help identify trends, yet paper remains important for people with limited digital access, vision impairment, low health literacy or language barriers. In Australia, pharmacies serving culturally diverse communities in Sydney or Western Sydney may need translated materials and interpreter pathways. Regional and remote services may also need workflows that work during unreliable internet access.
Connecting Measures to Pharmacy Services
Different pharmacy services require different outcome domains. A vaccination service may track confidence in future vaccination, understanding of expected reactions and ability to access follow-up care. A smoking cessation program may measure confidence, cravings, quit attempts, tobacco use and the patient’s sense of control rather than relying solely on abstinence at one checkpoint.
For respiratory care, patient-reported outcomes can complement technique checks and medicine histories. A structured consultation about breathlessness, activity limitation and confidence with devices can sit alongside practical education. Pharmacists looking to strengthen their counselling approach may find this inhaler counselling guidance useful when designing questions around inhaler use and self-management.
Medication reviews should examine the experience of treatment, not simply whether a medicine appears on the list. Useful questions may explore whether the regimen is difficult to follow, whether adverse effects interfere with daily life, and whether the patient understands the purpose of each medicine. These findings can guide prescriber communication, dose-timing changes, adherence aids or referral to another health professional.
Pharmacy-based oral health promotion provides another example. Patients may report pain, eating difficulty, embarrassment, or uncertainty about when to seek dental care. A resource such as this oral health resource can support broader conversations, although pharmacists should remain clear about the limits of their role and refer patients for dental assessment when needed.
Making Results Clinically Useful
The value of PROs comes from interpretation and action. A lower symptom score may indicate improvement, but it could also reflect temporary circumstances, misunderstanding of the questions, or a change in treatment elsewhere. Pharmacists should consider the result alongside medicine records, clinical observations, patient history and information from the general practitioner or specialist.
Individual results can support shared decision-making. Showing a patient that their confidence has increased, their symptoms have eased, or their daily routine remains difficult can make the next step more concrete. The conversation may lead to continued monitoring, a revised medication plan, referral, or a decision to stop an intervention that is not helping.
Aggregated results can show whether a service is working across a patient group. A pharmacy might compare baseline and follow-up scores for people receiving medication synchronisation, diabetes support or opioid treatment. Results should be reported with the number of participants, completion rates, time period and important limitations, rather than presented as a simple percentage without context.
When results are shared with pharmacists, assistants and managers, the discussion should focus on learning rather than blame. A lower score may signal that appointment times are too short, written instructions are unclear, or follow-up is inconsistent. This makes patient feedback a practical quality-improvement tool.
Protecting Quality And Equity
Reliable measurement depends on accessibility. Patients with limited English, cognitive impairment, hearing loss or low literacy may be under-represented if forms are complex or only available online. Providing assistance, translated resources, large-print options and an opportunity to answer verbally can make participation fairer.
Pharmacies should avoid treating a high satisfaction score as proof of clinical effectiveness. Patients may appreciate friendly staff even when a service fails to improve symptoms, and a clinically valuable intervention may produce mixed satisfaction if it involves difficult lifestyle changes. Experience and outcome measures should therefore be reviewed together.
- Use validated short measures where possible
- Record the patient’s own priority in plain language
- Offer verbal, paper and digital completion options
- Document follow-up actions after concerning responses
Privacy and consent also matter. Patients should know what is being collected, why it is needed, who can see it, and whether information will be used for service evaluation. Data should be stored securely and reported in a way that prevents identification, particularly in small rural communities where a combination of age, condition and location may reveal an individual.
- Separate service evaluation from marketing claims
- Set clear escalation rules for risk disclosures
- Review missing data by age, language and location
- Avoid comparing pharmacies without shared definitions
Turning Evidence Into Service Improvement
A practical improvement cycle can begin with a small pilot. One pharmacy might collect two patient-reported questions during medication reviews for six weeks, examine the findings, adjust the consultation process and repeat the measurement. This is more manageable than introducing a complex system across every service at once.
Teams should decide in advance what would prompt a change. If many patients report uncertainty about dose timing, the pharmacy could redesign labels or create a follow-up call. If patients report long waits for private consultations, the manager might adjust appointment spacing or identify a quieter time of day. Action makes data visible and gives staff a reason to keep collecting it.
Results can be displayed through run charts, brief monthly summaries or team huddles. A pharmacy may track the proportion of patients who report improved confidence, the average change in symptom burden, or the percentage receiving documented follow-up. Trends over time are generally more informative than a single result.
Australian pharmacies also operate within local funding and service realities. A service supported through a Primary Health Network partnership, a private program, or a community pharmacy initiative may have different reporting requirements. Aligning patient-reported outcomes with existing documentation reduces duplication and helps demonstrate value to funders, prescribers and professional bodies.
Embedding Patient Voice In Business Cases
A patient-centred evidence base can strengthen a proposal for new staff, consultation space, digital systems or expanded clinical services. Activity figures show demand, while PROs show whether the service changes something important to patients. Together, they create a more persuasive account than either type of evidence alone.
For example, a pharmacy seeking to expand diabetes support could report the number of consultations, changes in confidence managing medicines, patient-reported barriers to self-care, and referrals completed. It could also include anonymised patient comments that explain why the service matters in daily life. Quantitative data provides structure; carefully selected narratives provide meaning.
Results should be communicated in language suited to the audience. A prescriber may want to see symptom change and referral outcomes. A pharmacy owner may focus on staff time, retention and service sustainability. A health network may need information about access, equity and reduced pressure on other parts of the system.
Patient-reported outcomes can also support professional reflection. Pharmacists may discover that their explanation is technically accurate but poorly matched to patient priorities, or that follow-up is most valuable for people with multiple medicines. This insight can improve consultation skills, team training and collaboration with general practice, nursing, allied health and Aboriginal health services.
The most effective approach is modest, consistent and purposeful. Select a few outcomes, explain their relevance, collect them at useful points, and make sure every concerning result receives attention. Begin with one service and a small patient group, then refine the process before expanding it. Pharmacy teams that treat patient voice as clinical evidence will be better placed to show the real impact of their care and improve the experience of people who rely on it.